Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes

Vikash Dadlani, Jordan E. Pinsker, Eyal Dassau, Yogish C Kudva

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Purpose of Review: To provide a current review of closed-loop insulin delivery or artificial pancreas (AP) as therapy for people with type 1 diabetes mellitus (T1D) Recent Findings: The Medtronic Minimed 670G AP system has been in use in clinical practice since March 2017. Currently, Medtronic is conducting a large randomized clinical trial to evaluate its efficacy further in T1D. Simultaneously, the NIH has funded four research consortia to accelerate progress to approval of other AP and decision support systems. Several research groups are currently developing next-generation AP systems, with a number of companies moving toward releasing closed-loop systems in the future. AP systems are also being tested in select populations such as hypoglycemia-unaware T1D and pregnant T1D. Summary: AP research is rapidly advancing. The clinical range of AP will be expanded in the next decade.

Original languageEnglish (US)
Article number88
JournalCurrent Diabetes Reports
Volume18
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Artificial Pancreas
Type 1 Diabetes Mellitus
Insulin
Research
Hypoglycemia
Randomized Controlled Trials

Keywords

  • Artificial pancreas
  • Closed loop
  • Glycemic variability
  • Hypoglycemia
  • Type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes. / Dadlani, Vikash; Pinsker, Jordan E.; Dassau, Eyal; Kudva, Yogish C.

In: Current Diabetes Reports, Vol. 18, No. 10, 88, 01.10.2018.

Research output: Contribution to journalReview article

Dadlani, Vikash ; Pinsker, Jordan E. ; Dassau, Eyal ; Kudva, Yogish C. / Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes. In: Current Diabetes Reports. 2018 ; Vol. 18, No. 10.
@article{89c2f6a0f713480eb8fea5ef36f0aeed,
title = "Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes",
abstract = "Purpose of Review: To provide a current review of closed-loop insulin delivery or artificial pancreas (AP) as therapy for people with type 1 diabetes mellitus (T1D) Recent Findings: The Medtronic Minimed 670G AP system has been in use in clinical practice since March 2017. Currently, Medtronic is conducting a large randomized clinical trial to evaluate its efficacy further in T1D. Simultaneously, the NIH has funded four research consortia to accelerate progress to approval of other AP and decision support systems. Several research groups are currently developing next-generation AP systems, with a number of companies moving toward releasing closed-loop systems in the future. AP systems are also being tested in select populations such as hypoglycemia-unaware T1D and pregnant T1D. Summary: AP research is rapidly advancing. The clinical range of AP will be expanded in the next decade.",
keywords = "Artificial pancreas, Closed loop, Glycemic variability, Hypoglycemia, Type 1 diabetes",
author = "Vikash Dadlani and Pinsker, {Jordan E.} and Eyal Dassau and Kudva, {Yogish C}",
year = "2018",
month = "10",
day = "1",
doi = "10.1007/s11892-018-1051-z",
language = "English (US)",
volume = "18",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "10",

}

TY - JOUR

T1 - Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes

AU - Dadlani, Vikash

AU - Pinsker, Jordan E.

AU - Dassau, Eyal

AU - Kudva, Yogish C

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Purpose of Review: To provide a current review of closed-loop insulin delivery or artificial pancreas (AP) as therapy for people with type 1 diabetes mellitus (T1D) Recent Findings: The Medtronic Minimed 670G AP system has been in use in clinical practice since March 2017. Currently, Medtronic is conducting a large randomized clinical trial to evaluate its efficacy further in T1D. Simultaneously, the NIH has funded four research consortia to accelerate progress to approval of other AP and decision support systems. Several research groups are currently developing next-generation AP systems, with a number of companies moving toward releasing closed-loop systems in the future. AP systems are also being tested in select populations such as hypoglycemia-unaware T1D and pregnant T1D. Summary: AP research is rapidly advancing. The clinical range of AP will be expanded in the next decade.

AB - Purpose of Review: To provide a current review of closed-loop insulin delivery or artificial pancreas (AP) as therapy for people with type 1 diabetes mellitus (T1D) Recent Findings: The Medtronic Minimed 670G AP system has been in use in clinical practice since March 2017. Currently, Medtronic is conducting a large randomized clinical trial to evaluate its efficacy further in T1D. Simultaneously, the NIH has funded four research consortia to accelerate progress to approval of other AP and decision support systems. Several research groups are currently developing next-generation AP systems, with a number of companies moving toward releasing closed-loop systems in the future. AP systems are also being tested in select populations such as hypoglycemia-unaware T1D and pregnant T1D. Summary: AP research is rapidly advancing. The clinical range of AP will be expanded in the next decade.

KW - Artificial pancreas

KW - Closed loop

KW - Glycemic variability

KW - Hypoglycemia

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85052551981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052551981&partnerID=8YFLogxK

U2 - 10.1007/s11892-018-1051-z

DO - 10.1007/s11892-018-1051-z

M3 - Review article

VL - 18

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 10

M1 - 88

ER -